The STING protein, known for helping cells fight viral infections by generating inflammation, also appears to function as a ...

Kanazawa University, report in Nature Communications on how the targeted suppression of lysosome function may lead to brain ...

Parkinson's disease is the second most common neurodegenerative disease in the world... | Genetics And Genomics ...

In animal models, NU-9 was found to show promise in treating Alzheimer's by reducing toxic protein buildup and brain ...

Kanazawa University, report in Nature Communications how the targeted suppression of lysosome function may lead to brain ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who also ...

CRISPR technology uncovers new key genes and pathways linked to Parkinson’s disease, offering insights into risk and ...

A longstanding mystery in Parkinson's disease research has been why some individuals carrying pathogenic variants that ...

US researchers have used modern technology CRISPR interference to identify a new set of genes that contribute to the risk of ...

Experimental drug NU-9 -- a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS) -- improves ...